Global Clinical Trial Imaging

Clinical Trial Imaging Comprehensive Study by Type (Services (Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services), Software), Mode (Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, X-Ray, Echocardiography, Others (Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry)), End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations, Academic and Government Research Institutes) Players and Region - Global Market Outlook to 2027

Clinical Trial Imaging Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 7.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Clinical Trial Imaging Market Overview:
Medical imaging plays a very important role in the process of clinical development of various kinds of novel life science products. Although the medical imaging industry is constantly volatile, the biotechnology and pharmaceutical industries continue to grow. This is due to increased investments in medical imaging companies as well as mergers and acquisitions and the introduction of innovative imaging technologies to support clinical trials for medical devices. However, the high cost of machines and their installation, as well as the large capital required to conduct clinical studies, can stifle the growth of the market. Advances in technology enable significant improvements in the collection, evaluation, and communication of imaging data for clinical trials. Technology-based imaging, particularly image analysis software, offers numerous benefits, including data accuracy, consistency, adaptability, and compliance with clinical trials. For example, image analysis software is implemented in order to manage and control a reader via the analysis of imaging times. The increasing use of technology, along with improved computing power, increases the use of imaging in clinical trials. Clinical trials are thus a very much important part of the process of drug development. However, the cost of conducting these clinical trials has hereby increased in recent years. Therefore, clinical trial imaging is emerging as an alternative measure that can help reduce drug trial costs, thereby improving the clinical trial schedule. As per latest study released by AMA Research, the Global Clinical Trial Imaging market is expected to see growth rate of 7.9% and may see market size of USD1.76 Billion by 2027.

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Billion)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Growth Drivers
  • The Rising Prevalence of Chronic Diseases
  • The Increasing Geriatric Population
  • Rise in Number of Contract Research Organization

Roadblocks
  • The High Cost of Machinery and Their Installation
  • High Implementation Barriers

Opportunities
  • The Rise in the Number of Biotechnology and Pharmaceutical Companies
  • Increase in R&D by Growing Pharmaceutical and Biotechnology Industries
  • The Increased Funding and Investment in the Field of Clinical Research and Clinical Trials

Challenges
  • The Enormous Cost of Clinical Trials


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are BioClinica, Inc. (United States), Biomedical Systems (United States), Cardiovascular Imaging Technologies (United States), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (United States), Medpace (United States), Resonance Health Ltd. (Australia), Navitas Life Sciences (United States), IXICO, PLC (United Kingdom) and PAREXEL International Corporation (United States). Additionally, following companies can also be profiled that are part of our coverage like Radiant Sage, LLC, BioTelemetric, Inc. and WorldCare Clinical, LLC. Analyst at AMA Research see United States Players to retain maximum share of Global Clinical Trial Imaging market by 2027. Considering Market by Mode, the sub-segment i.e. Computed Tomography will boost the Clinical Trial Imaging market. Considering Market by End User, the sub-segment i.e. Pharmaceutical Companies will boost the Clinical Trial Imaging market.

Latest Market Insights:
In February 2020, ICON plc had acquired MedPass International, which is a European CRO for medical devices, reimbursement, and regulatory advice. This acquisition would in turn help expand ICON's medical device and diagnostic research services in Europe.

In June 2018, Bioclinica had introduced the SMART technology suite, which is available with the feature of Medical Imaging, Interactive Response Technology (IRT), as well as Electronic Data Capture (EDC) so as to transmit and manage medical image data in accordance with general data protection regulations and all the global requirements, for the purpose of submitting, investigating, and reporting.

What Can be Explored with the Clinical Trial Imaging Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Clinical Trial Imaging Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Clinical Trial Imaging
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Clinical Trial Imaging market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Clinical Trial Imaging market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Clinical Trial Imaging, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services]
  • Software
By Mode
  • Computed Tomography
  • Magnetic Resonance Imaging
  • Positron Emission Tomography
  • Ultrasound
  • X-Ray
  • Echocardiography
  • Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry]

By End User
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Manufacturers
  • Contract Research Organizations
  • Academic and Government Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Rising Prevalence of Chronic Diseases
      • 3.2.2. The Increasing Geriatric Population
      • 3.2.3. Rise in Number of Contract Research Organization
    • 3.3. Market Challenges
      • 3.3.1. The Enormous Cost of Clinical Trials
    • 3.4. Market Trends
      • 3.4.1. The Rising Trend in the Adoption of Innovative Imaging Technologies to Support Clinical Trials for the Medical Device
      • 3.4.2. The Rise in the Number of Drug Discoveries
      • 3.4.3. The Advancements in Healthcare Infrastructure
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Clinical Trial Imaging, by Type, Mode, End User and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Clinical Trial Imaging (Value)
      • 5.2.1. Global Clinical Trial Imaging by: Type (Value)
        • 5.2.1.1. Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services]
        • 5.2.1.2. Software
      • 5.2.2. Global Clinical Trial Imaging by: Mode (Value)
        • 5.2.2.1. Computed Tomography
        • 5.2.2.2. Magnetic Resonance Imaging
        • 5.2.2.3. Positron Emission Tomography
        • 5.2.2.4. Ultrasound
        • 5.2.2.5. X-Ray
        • 5.2.2.6. Echocardiography
        • 5.2.2.7. Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry]
      • 5.2.3. Global Clinical Trial Imaging by: End User (Value)
        • 5.2.3.1. Pharmaceutical Companies
        • 5.2.3.2. Biotechnology Companies
        • 5.2.3.3. Medical Device Manufacturers
        • 5.2.3.4. Contract Research Organizations
        • 5.2.3.5. Academic and Government Research Institutes
      • 5.2.4. Global Clinical Trial Imaging Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Clinical Trial Imaging (Volume)
      • 5.3.1. Global Clinical Trial Imaging by: Type (Volume)
        • 5.3.1.1. Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services]
        • 5.3.1.2. Software
      • 5.3.2. Global Clinical Trial Imaging by: Mode (Volume)
        • 5.3.2.1. Computed Tomography
        • 5.3.2.2. Magnetic Resonance Imaging
        • 5.3.2.3. Positron Emission Tomography
        • 5.3.2.4. Ultrasound
        • 5.3.2.5. X-Ray
        • 5.3.2.6. Echocardiography
        • 5.3.2.7. Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry]
      • 5.3.3. Global Clinical Trial Imaging by: End User (Volume)
        • 5.3.3.1. Pharmaceutical Companies
        • 5.3.3.2. Biotechnology Companies
        • 5.3.3.3. Medical Device Manufacturers
        • 5.3.3.4. Contract Research Organizations
        • 5.3.3.5. Academic and Government Research Institutes
      • 5.3.4. Global Clinical Trial Imaging Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Clinical Trial Imaging (Price)
      • 5.4.1. Global Clinical Trial Imaging by: Type (Price)
  • 6. Clinical Trial Imaging: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BioClinica, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Biomedical Systems (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cardiovascular Imaging Technologies (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. ICON Public Limited Company (Ireland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Intrinsic Imaging, LLC (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Medpace (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Resonance Health Ltd. (Australia)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Navitas Life Sciences (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. IXICO, PLC (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. PAREXEL International Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Clinical Trial Imaging Sale, by Type, Mode, End User and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Clinical Trial Imaging (Value)
      • 7.2.1. Global Clinical Trial Imaging by: Type (Value)
        • 7.2.1.1. Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services]
        • 7.2.1.2. Software
      • 7.2.2. Global Clinical Trial Imaging by: Mode (Value)
        • 7.2.2.1. Computed Tomography
        • 7.2.2.2. Magnetic Resonance Imaging
        • 7.2.2.3. Positron Emission Tomography
        • 7.2.2.4. Ultrasound
        • 7.2.2.5. X-Ray
        • 7.2.2.6. Echocardiography
        • 7.2.2.7. Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry]
      • 7.2.3. Global Clinical Trial Imaging by: End User (Value)
        • 7.2.3.1. Pharmaceutical Companies
        • 7.2.3.2. Biotechnology Companies
        • 7.2.3.3. Medical Device Manufacturers
        • 7.2.3.4. Contract Research Organizations
        • 7.2.3.5. Academic and Government Research Institutes
      • 7.2.4. Global Clinical Trial Imaging Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Clinical Trial Imaging (Volume)
      • 7.3.1. Global Clinical Trial Imaging by: Type (Volume)
        • 7.3.1.1. Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services]
        • 7.3.1.2. Software
      • 7.3.2. Global Clinical Trial Imaging by: Mode (Volume)
        • 7.3.2.1. Computed Tomography
        • 7.3.2.2. Magnetic Resonance Imaging
        • 7.3.2.3. Positron Emission Tomography
        • 7.3.2.4. Ultrasound
        • 7.3.2.5. X-Ray
        • 7.3.2.6. Echocardiography
        • 7.3.2.7. Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry]
      • 7.3.3. Global Clinical Trial Imaging by: End User (Volume)
        • 7.3.3.1. Pharmaceutical Companies
        • 7.3.3.2. Biotechnology Companies
        • 7.3.3.3. Medical Device Manufacturers
        • 7.3.3.4. Contract Research Organizations
        • 7.3.3.5. Academic and Government Research Institutes
      • 7.3.4. Global Clinical Trial Imaging Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Clinical Trial Imaging (Price)
      • 7.4.1. Global Clinical Trial Imaging by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Clinical Trial Imaging: by Type(USD Billion)
  • Table 2. Clinical Trial Imaging Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services] , by Region USD Billion (2016-2021)
  • Table 3. Clinical Trial Imaging Software , by Region USD Billion (2016-2021)
  • Table 4. Clinical Trial Imaging: by Mode(USD Billion)
  • Table 5. Clinical Trial Imaging Computed Tomography , by Region USD Billion (2016-2021)
  • Table 6. Clinical Trial Imaging Magnetic Resonance Imaging , by Region USD Billion (2016-2021)
  • Table 7. Clinical Trial Imaging Positron Emission Tomography , by Region USD Billion (2016-2021)
  • Table 8. Clinical Trial Imaging Ultrasound , by Region USD Billion (2016-2021)
  • Table 9. Clinical Trial Imaging X-Ray , by Region USD Billion (2016-2021)
  • Table 10. Clinical Trial Imaging Echocardiography , by Region USD Billion (2016-2021)
  • Table 11. Clinical Trial Imaging Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry] , by Region USD Billion (2016-2021)
  • Table 12. Clinical Trial Imaging: by End User(USD Billion)
  • Table 13. Clinical Trial Imaging Pharmaceutical Companies , by Region USD Billion (2016-2021)
  • Table 14. Clinical Trial Imaging Biotechnology Companies , by Region USD Billion (2016-2021)
  • Table 15. Clinical Trial Imaging Medical Device Manufacturers , by Region USD Billion (2016-2021)
  • Table 16. Clinical Trial Imaging Contract Research Organizations , by Region USD Billion (2016-2021)
  • Table 17. Clinical Trial Imaging Academic and Government Research Institutes , by Region USD Billion (2016-2021)
  • Table 18. South America Clinical Trial Imaging, by Country USD Billion (2016-2021)
  • Table 19. South America Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 20. South America Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 21. South America Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 22. Brazil Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 23. Brazil Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 24. Brazil Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 25. Argentina Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 26. Argentina Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 27. Argentina Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 28. Rest of South America Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 29. Rest of South America Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 30. Rest of South America Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 31. Asia Pacific Clinical Trial Imaging, by Country USD Billion (2016-2021)
  • Table 32. Asia Pacific Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 33. Asia Pacific Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 34. Asia Pacific Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 35. China Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 36. China Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 37. China Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 38. Japan Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 39. Japan Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 40. Japan Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 41. India Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 42. India Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 43. India Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 44. South Korea Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 45. South Korea Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 46. South Korea Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 47. Taiwan Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 48. Taiwan Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 49. Taiwan Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 50. Australia Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 51. Australia Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 52. Australia Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 53. Rest of Asia-Pacific Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 54. Rest of Asia-Pacific Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 55. Rest of Asia-Pacific Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 56. Europe Clinical Trial Imaging, by Country USD Billion (2016-2021)
  • Table 57. Europe Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 58. Europe Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 59. Europe Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 60. Germany Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 61. Germany Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 62. Germany Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 63. France Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 64. France Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 65. France Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 66. Italy Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 67. Italy Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 68. Italy Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 69. United Kingdom Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 70. United Kingdom Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 71. United Kingdom Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 72. Netherlands Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 73. Netherlands Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 74. Netherlands Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 75. Rest of Europe Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 76. Rest of Europe Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 77. Rest of Europe Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 78. MEA Clinical Trial Imaging, by Country USD Billion (2016-2021)
  • Table 79. MEA Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 80. MEA Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 81. MEA Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 82. Middle East Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 83. Middle East Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 84. Middle East Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 85. Africa Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 86. Africa Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 87. Africa Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 88. North America Clinical Trial Imaging, by Country USD Billion (2016-2021)
  • Table 89. North America Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 90. North America Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 91. North America Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 92. United States Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 93. United States Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 94. United States Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 95. Canada Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 96. Canada Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 97. Canada Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 98. Mexico Clinical Trial Imaging, by Type USD Billion (2016-2021)
  • Table 99. Mexico Clinical Trial Imaging, by Mode USD Billion (2016-2021)
  • Table 100. Mexico Clinical Trial Imaging, by End User USD Billion (2016-2021)
  • Table 101. Clinical Trial Imaging Sales: by Type(K Units)
  • Table 102. Clinical Trial Imaging Sales Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services] , by Region K Units (2016-2021)
  • Table 103. Clinical Trial Imaging Sales Software , by Region K Units (2016-2021)
  • Table 104. Clinical Trial Imaging Sales: by Mode(K Units)
  • Table 105. Clinical Trial Imaging Sales Computed Tomography , by Region K Units (2016-2021)
  • Table 106. Clinical Trial Imaging Sales Magnetic Resonance Imaging , by Region K Units (2016-2021)
  • Table 107. Clinical Trial Imaging Sales Positron Emission Tomography , by Region K Units (2016-2021)
  • Table 108. Clinical Trial Imaging Sales Ultrasound , by Region K Units (2016-2021)
  • Table 109. Clinical Trial Imaging Sales X-Ray , by Region K Units (2016-2021)
  • Table 110. Clinical Trial Imaging Sales Echocardiography , by Region K Units (2016-2021)
  • Table 111. Clinical Trial Imaging Sales Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry] , by Region K Units (2016-2021)
  • Table 112. Clinical Trial Imaging Sales: by End User(K Units)
  • Table 113. Clinical Trial Imaging Sales Pharmaceutical Companies , by Region K Units (2016-2021)
  • Table 114. Clinical Trial Imaging Sales Biotechnology Companies , by Region K Units (2016-2021)
  • Table 115. Clinical Trial Imaging Sales Medical Device Manufacturers , by Region K Units (2016-2021)
  • Table 116. Clinical Trial Imaging Sales Contract Research Organizations , by Region K Units (2016-2021)
  • Table 117. Clinical Trial Imaging Sales Academic and Government Research Institutes , by Region K Units (2016-2021)
  • Table 118. South America Clinical Trial Imaging Sales, by Country K Units (2016-2021)
  • Table 119. South America Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 120. South America Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 121. South America Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 122. Brazil Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 123. Brazil Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 124. Brazil Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 125. Argentina Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 126. Argentina Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 127. Argentina Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 128. Rest of South America Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 129. Rest of South America Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 130. Rest of South America Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 131. Asia Pacific Clinical Trial Imaging Sales, by Country K Units (2016-2021)
  • Table 132. Asia Pacific Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 133. Asia Pacific Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 134. Asia Pacific Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 135. China Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 136. China Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 137. China Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 138. Japan Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 139. Japan Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 140. Japan Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 141. India Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 142. India Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 143. India Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 144. South Korea Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 145. South Korea Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 146. South Korea Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 147. Taiwan Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 148. Taiwan Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 149. Taiwan Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 150. Australia Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 151. Australia Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 152. Australia Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 153. Rest of Asia-Pacific Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 154. Rest of Asia-Pacific Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 155. Rest of Asia-Pacific Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 156. Europe Clinical Trial Imaging Sales, by Country K Units (2016-2021)
  • Table 157. Europe Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 158. Europe Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 159. Europe Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 160. Germany Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 161. Germany Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 162. Germany Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 163. France Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 164. France Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 165. France Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 166. Italy Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 167. Italy Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 168. Italy Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 169. United Kingdom Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 170. United Kingdom Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 171. United Kingdom Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 172. Netherlands Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 173. Netherlands Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 174. Netherlands Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 175. Rest of Europe Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 176. Rest of Europe Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 177. Rest of Europe Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 178. MEA Clinical Trial Imaging Sales, by Country K Units (2016-2021)
  • Table 179. MEA Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 180. MEA Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 181. MEA Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 182. Middle East Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 183. Middle East Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 184. Middle East Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 185. Africa Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 186. Africa Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 187. Africa Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 188. North America Clinical Trial Imaging Sales, by Country K Units (2016-2021)
  • Table 189. North America Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 190. North America Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 191. North America Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 192. United States Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 193. United States Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 194. United States Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 195. Canada Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 196. Canada Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 197. Canada Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 198. Mexico Clinical Trial Imaging Sales, by Type K Units (2016-2021)
  • Table 199. Mexico Clinical Trial Imaging Sales, by Mode K Units (2016-2021)
  • Table 200. Mexico Clinical Trial Imaging Sales, by End User K Units (2016-2021)
  • Table 201. Clinical Trial Imaging: by Type(USD/Units)
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Clinical Trial Imaging: by Type(USD Billion)
  • Table 213. Clinical Trial Imaging Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services] , by Region USD Billion (2022-2027)
  • Table 214. Clinical Trial Imaging Software , by Region USD Billion (2022-2027)
  • Table 215. Clinical Trial Imaging: by Mode(USD Billion)
  • Table 216. Clinical Trial Imaging Computed Tomography , by Region USD Billion (2022-2027)
  • Table 217. Clinical Trial Imaging Magnetic Resonance Imaging , by Region USD Billion (2022-2027)
  • Table 218. Clinical Trial Imaging Positron Emission Tomography , by Region USD Billion (2022-2027)
  • Table 219. Clinical Trial Imaging Ultrasound , by Region USD Billion (2022-2027)
  • Table 220. Clinical Trial Imaging X-Ray , by Region USD Billion (2022-2027)
  • Table 221. Clinical Trial Imaging Echocardiography , by Region USD Billion (2022-2027)
  • Table 222. Clinical Trial Imaging Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry] , by Region USD Billion (2022-2027)
  • Table 223. Clinical Trial Imaging: by End User(USD Billion)
  • Table 224. Clinical Trial Imaging Pharmaceutical Companies , by Region USD Billion (2022-2027)
  • Table 225. Clinical Trial Imaging Biotechnology Companies , by Region USD Billion (2022-2027)
  • Table 226. Clinical Trial Imaging Medical Device Manufacturers , by Region USD Billion (2022-2027)
  • Table 227. Clinical Trial Imaging Contract Research Organizations , by Region USD Billion (2022-2027)
  • Table 228. Clinical Trial Imaging Academic and Government Research Institutes , by Region USD Billion (2022-2027)
  • Table 229. South America Clinical Trial Imaging, by Country USD Billion (2022-2027)
  • Table 230. South America Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 231. South America Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 232. South America Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 233. Brazil Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 234. Brazil Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 235. Brazil Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 236. Argentina Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 237. Argentina Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 238. Argentina Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 239. Rest of South America Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 240. Rest of South America Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 241. Rest of South America Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 242. Asia Pacific Clinical Trial Imaging, by Country USD Billion (2022-2027)
  • Table 243. Asia Pacific Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 244. Asia Pacific Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 245. Asia Pacific Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 246. China Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 247. China Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 248. China Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 249. Japan Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 250. Japan Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 251. Japan Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 252. India Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 253. India Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 254. India Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 255. South Korea Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 256. South Korea Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 257. South Korea Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 258. Taiwan Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 259. Taiwan Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 260. Taiwan Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 261. Australia Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 262. Australia Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 263. Australia Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 264. Rest of Asia-Pacific Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 265. Rest of Asia-Pacific Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 266. Rest of Asia-Pacific Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 267. Europe Clinical Trial Imaging, by Country USD Billion (2022-2027)
  • Table 268. Europe Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 269. Europe Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 270. Europe Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 271. Germany Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 272. Germany Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 273. Germany Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 274. France Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 275. France Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 276. France Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 277. Italy Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 278. Italy Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 279. Italy Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 280. United Kingdom Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 281. United Kingdom Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 282. United Kingdom Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 283. Netherlands Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 284. Netherlands Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 285. Netherlands Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 286. Rest of Europe Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 287. Rest of Europe Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 288. Rest of Europe Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 289. MEA Clinical Trial Imaging, by Country USD Billion (2022-2027)
  • Table 290. MEA Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 291. MEA Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 292. MEA Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 293. Middle East Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 294. Middle East Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 295. Middle East Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 296. Africa Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 297. Africa Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 298. Africa Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 299. North America Clinical Trial Imaging, by Country USD Billion (2022-2027)
  • Table 300. North America Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 301. North America Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 302. North America Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 303. United States Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 304. United States Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 305. United States Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 306. Canada Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 307. Canada Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 308. Canada Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 309. Mexico Clinical Trial Imaging, by Type USD Billion (2022-2027)
  • Table 310. Mexico Clinical Trial Imaging, by Mode USD Billion (2022-2027)
  • Table 311. Mexico Clinical Trial Imaging, by End User USD Billion (2022-2027)
  • Table 312. Clinical Trial Imaging Sales: by Type(K Units)
  • Table 313. Clinical Trial Imaging Sales Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services] , by Region K Units (2022-2027)
  • Table 314. Clinical Trial Imaging Sales Software , by Region K Units (2022-2027)
  • Table 315. Clinical Trial Imaging Sales: by Mode(K Units)
  • Table 316. Clinical Trial Imaging Sales Computed Tomography , by Region K Units (2022-2027)
  • Table 317. Clinical Trial Imaging Sales Magnetic Resonance Imaging , by Region K Units (2022-2027)
  • Table 318. Clinical Trial Imaging Sales Positron Emission Tomography , by Region K Units (2022-2027)
  • Table 319. Clinical Trial Imaging Sales Ultrasound , by Region K Units (2022-2027)
  • Table 320. Clinical Trial Imaging Sales X-Ray , by Region K Units (2022-2027)
  • Table 321. Clinical Trial Imaging Sales Echocardiography , by Region K Units (2022-2027)
  • Table 322. Clinical Trial Imaging Sales Others [Magnetic Resonance Elastography, Dual-energy X-ray Absorptiometry] , by Region K Units (2022-2027)
  • Table 323. Clinical Trial Imaging Sales: by End User(K Units)
  • Table 324. Clinical Trial Imaging Sales Pharmaceutical Companies , by Region K Units (2022-2027)
  • Table 325. Clinical Trial Imaging Sales Biotechnology Companies , by Region K Units (2022-2027)
  • Table 326. Clinical Trial Imaging Sales Medical Device Manufacturers , by Region K Units (2022-2027)
  • Table 327. Clinical Trial Imaging Sales Contract Research Organizations , by Region K Units (2022-2027)
  • Table 328. Clinical Trial Imaging Sales Academic and Government Research Institutes , by Region K Units (2022-2027)
  • Table 329. South America Clinical Trial Imaging Sales, by Country K Units (2022-2027)
  • Table 330. South America Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 331. South America Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 332. South America Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 333. Brazil Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 334. Brazil Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 335. Brazil Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 336. Argentina Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 337. Argentina Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 338. Argentina Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 339. Rest of South America Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 340. Rest of South America Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 341. Rest of South America Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 342. Asia Pacific Clinical Trial Imaging Sales, by Country K Units (2022-2027)
  • Table 343. Asia Pacific Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 344. Asia Pacific Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 345. Asia Pacific Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 346. China Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 347. China Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 348. China Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 349. Japan Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 350. Japan Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 351. Japan Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 352. India Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 353. India Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 354. India Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 355. South Korea Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 356. South Korea Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 357. South Korea Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 358. Taiwan Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 359. Taiwan Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 360. Taiwan Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 361. Australia Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 362. Australia Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 363. Australia Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 364. Rest of Asia-Pacific Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 365. Rest of Asia-Pacific Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 366. Rest of Asia-Pacific Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 367. Europe Clinical Trial Imaging Sales, by Country K Units (2022-2027)
  • Table 368. Europe Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 369. Europe Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 370. Europe Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 371. Germany Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 372. Germany Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 373. Germany Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 374. France Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 375. France Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 376. France Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 377. Italy Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 378. Italy Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 379. Italy Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 380. United Kingdom Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 381. United Kingdom Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 382. United Kingdom Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 383. Netherlands Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 384. Netherlands Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 385. Netherlands Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 386. Rest of Europe Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 387. Rest of Europe Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 388. Rest of Europe Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 389. MEA Clinical Trial Imaging Sales, by Country K Units (2022-2027)
  • Table 390. MEA Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 391. MEA Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 392. MEA Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 393. Middle East Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 394. Middle East Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 395. Middle East Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 396. Africa Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 397. Africa Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 398. Africa Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 399. North America Clinical Trial Imaging Sales, by Country K Units (2022-2027)
  • Table 400. North America Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 401. North America Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 402. North America Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 403. United States Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 404. United States Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 405. United States Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 406. Canada Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 407. Canada Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 408. Canada Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 409. Mexico Clinical Trial Imaging Sales, by Type K Units (2022-2027)
  • Table 410. Mexico Clinical Trial Imaging Sales, by Mode K Units (2022-2027)
  • Table 411. Mexico Clinical Trial Imaging Sales, by End User K Units (2022-2027)
  • Table 412. Clinical Trial Imaging: by Type(USD/Units)
  • Table 413. Research Programs/Design for This Report
  • Table 414. Key Data Information from Secondary Sources
  • Table 415. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Clinical Trial Imaging: by Type USD Billion (2016-2021)
  • Figure 5. Global Clinical Trial Imaging: by Mode USD Billion (2016-2021)
  • Figure 6. Global Clinical Trial Imaging: by End User USD Billion (2016-2021)
  • Figure 7. South America Clinical Trial Imaging Share (%), by Country
  • Figure 8. Asia Pacific Clinical Trial Imaging Share (%), by Country
  • Figure 9. Europe Clinical Trial Imaging Share (%), by Country
  • Figure 10. MEA Clinical Trial Imaging Share (%), by Country
  • Figure 11. North America Clinical Trial Imaging Share (%), by Country
  • Figure 12. Global Clinical Trial Imaging: by Type K Units (2016-2021)
  • Figure 13. Global Clinical Trial Imaging: by Mode K Units (2016-2021)
  • Figure 14. Global Clinical Trial Imaging: by End User K Units (2016-2021)
  • Figure 15. South America Clinical Trial Imaging Share (%), by Country
  • Figure 16. Asia Pacific Clinical Trial Imaging Share (%), by Country
  • Figure 17. Europe Clinical Trial Imaging Share (%), by Country
  • Figure 18. MEA Clinical Trial Imaging Share (%), by Country
  • Figure 19. North America Clinical Trial Imaging Share (%), by Country
  • Figure 20. Global Clinical Trial Imaging: by Type USD/Units (2016-2021)
  • Figure 21. Global Clinical Trial Imaging share by Players 2021 (%)
  • Figure 22. Global Clinical Trial Imaging share by Players (Top 3) 2021(%)
  • Figure 23. Global Clinical Trial Imaging share by Players (Top 5) 2021(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. BioClinica, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. BioClinica, Inc. (United States) Revenue: by Geography 2021
  • Figure 27. Biomedical Systems (United States) Revenue, Net Income and Gross profit
  • Figure 28. Biomedical Systems (United States) Revenue: by Geography 2021
  • Figure 29. Cardiovascular Imaging Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 30. Cardiovascular Imaging Technologies (United States) Revenue: by Geography 2021
  • Figure 31. ICON Public Limited Company (Ireland) Revenue, Net Income and Gross profit
  • Figure 32. ICON Public Limited Company (Ireland) Revenue: by Geography 2021
  • Figure 33. Intrinsic Imaging, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 34. Intrinsic Imaging, LLC (United States) Revenue: by Geography 2021
  • Figure 35. Medpace (United States) Revenue, Net Income and Gross profit
  • Figure 36. Medpace (United States) Revenue: by Geography 2021
  • Figure 37. Resonance Health Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 38. Resonance Health Ltd. (Australia) Revenue: by Geography 2021
  • Figure 39. Navitas Life Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 40. Navitas Life Sciences (United States) Revenue: by Geography 2021
  • Figure 41. IXICO, PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 42. IXICO, PLC (United Kingdom) Revenue: by Geography 2021
  • Figure 43. PAREXEL International Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 44. PAREXEL International Corporation (United States) Revenue: by Geography 2021
  • Figure 45. Global Clinical Trial Imaging: by Type USD Billion (2022-2027)
  • Figure 46. Global Clinical Trial Imaging: by Mode USD Billion (2022-2027)
  • Figure 47. Global Clinical Trial Imaging: by End User USD Billion (2022-2027)
  • Figure 48. South America Clinical Trial Imaging Share (%), by Country
  • Figure 49. Asia Pacific Clinical Trial Imaging Share (%), by Country
  • Figure 50. Europe Clinical Trial Imaging Share (%), by Country
  • Figure 51. MEA Clinical Trial Imaging Share (%), by Country
  • Figure 52. North America Clinical Trial Imaging Share (%), by Country
  • Figure 53. Global Clinical Trial Imaging: by Type K Units (2022-2027)
  • Figure 54. Global Clinical Trial Imaging: by Mode K Units (2022-2027)
  • Figure 55. Global Clinical Trial Imaging: by End User K Units (2022-2027)
  • Figure 56. South America Clinical Trial Imaging Share (%), by Country
  • Figure 57. Asia Pacific Clinical Trial Imaging Share (%), by Country
  • Figure 58. Europe Clinical Trial Imaging Share (%), by Country
  • Figure 59. MEA Clinical Trial Imaging Share (%), by Country
  • Figure 60. North America Clinical Trial Imaging Share (%), by Country
  • Figure 61. Global Clinical Trial Imaging: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • BioClinica, Inc. (United States)
  • Biomedical Systems (United States)
  • Cardiovascular Imaging Technologies (United States)
  • ICON Public Limited Company (Ireland)
  • Intrinsic Imaging, LLC (United States)
  • Medpace (United States)
  • Resonance Health Ltd. (Australia)
  • Navitas Life Sciences (United States)
  • IXICO, PLC (United Kingdom)
  • PAREXEL International Corporation (United States)
Additional players considered in the study are as follows:
Radiant Sage, LLC , BioTelemetric, Inc. , WorldCare Clinical, LLC
Select User Access Type

Key Highlights of Report


Jul 2022 189 Pages 54 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Clinical Trial Imaging Quantitative research analysis
Global Clinical Trial Imaging Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Clinical Trial Imaging market are BioClinica, Inc. (United States), Biomedical Systems (United States), Cardiovascular Imaging Technologies (United States), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (United States), Medpace (United States), Resonance Health Ltd. (Australia), Navitas Life Sciences (United States), IXICO, PLC (United Kingdom) and PAREXEL International Corporation (United States), to name a few.
"The Rising Trend in the Adoption of Innovative Imaging Technologies to Support Clinical Trials for the Medical Device " is seen as one of major influencing trends for Clinical Trial Imaging Market during projected period 2021-2027.
Services [Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services] segment in Global market to hold robust market share owing to "The Rising Prevalence of Chronic Diseases ".
Pharmaceutical Companies dominated the Clinical Trial Imaging market. This is attributable due to "The Rising Prevalence of Chronic Diseases "
Consultation Services dominated the Clinical Trial Imaging market. This is attributable to growing trend of "The Rising Trend in the Adoption of Innovative Imaging Technologies to Support Clinical Trials for the Medical Device "

Know More About Global Clinical Trial Imaging Report?

Have a Query? Click Here

Other Related Reports

Knee Replacement Implants Comprehensive Study by Procedure (Total Knee Replacement, Partial Knee Replacement, Revision Knee Replacement), Component (Fixed Bearing Implants, Mobile Bearing Implants)...
$ 3650
DNA Sequencing Instruments Comprehensive Study by Type (Consumable, Instrument, Service), Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, Other...
$ 3750
Artificial Joints Comprehensive Study by Type (Cemented Joints, Non-Cemented Joints), Application (Artificial Joints of Knee, Artificial Joints of Hip, Artificial Joints of Shoulder, Other), Material...
$ 3450
Healthcare BI Platform Comprehensive Study by Application (Data mining, Real-time reporting, Big Data processing, Clinical decision support, Predictive analytics), Organization Size (SMBs, Large E...
$ 3650
Behavioral Mental Health Software - Comprehensive Study by Type (Software, Support Services, Integrated Software, Standalone Software), End users (Hospitals, Private Practices, Patients, Providers (H...
$ 3750
Medical Digital Imaging System Comprehensive Study by Type (X-ray, Magnetic Resonance Imaging (MRI), Ultrasound, Computed Tomography (CT) Scanners, Nuclear Imaging), Application (General Radiography,...
$ 3650